GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer.
Bhat RR, Yadav P, Sahay D, Bhargava DK, Creighton CJ, Yazdanfard S, Al-Rawi A, Yadav V, Qin L, Nanda S, Sethunath V, Fu X, De Angelis C, Narkar VA, Osborne CK, Schiff R, Trivedi MV.
Bhat RR, et al. Among authors: sahay d.
Breast Cancer Res Treat. 2018 Jul;170(2):279-292. doi: 10.1007/s10549-018-4751-9. Epub 2018 Mar 24.
Breast Cancer Res Treat. 2018.
PMID: 29574636
Free PMC article.